Title: Anesthesia Drugs Market in U.S. worth $7 Billion by 2015
1MarketsandMarkets Presents
Anesthesia Drugs Market in U.S. worth 7 Billion
by 2015
2The Anesthesia Drugs Market (2011 - 2015) - U.S.
Market Entry Study analyzes and studies the U.S.
market for intravenous anesthesia drugs with
special focus on ketamine, distribution structure
of anesthesia drugs in U.S., potential buyers,
export import system for controlled substances
in U.S. and U.S. market entry strategy. Browse
market data tables and in-depth TOC of
Anesthesia Drugs Market (2011 - 2015) - U.S.
Market Entry Study. http//www.marketsandmarkets
.com/Market-Reports/anesthesia-drugs-ketamine-mark
et-713.html This report studies the U.S.
Ketamine market over the period of 2007-2015.
Ketamine market is expected to grow at a moderate
rate from 2011 to 2016. Anesthesia is a condition
in which sensation is totally or partially
blocked. This enables the patients to undergo
medical procedures and surgery.
3- General anesthesia includes blockage of pain,
awareness, and memory. Advantages offered by
general anesthesia includes - rapid onset of
anesthesia, full control of the body processes
(airway, respiratory and circulatory system),
used in surgeries with unpredictable duration of
surgery, no memory of the surgery, allows
complete motionlessness over prolonged duration
of the surgery and it permits simultaneous
operation on different body parts. - General anesthesia drugs involve inhalation and
intravenous anesthesia drugs. Report is specially
focused on general intravenous anesthesia drugs
category. Drugs such as propofol, midazolam
diazepam, fospropofol disodium, sodium pentothal,
ketamine, methohexital sodium, pentobarbital,
etomidate, and fentanyl are studied.
4- 3. The U.S. general anesthesia market size was
approximately 2 billion in 2011 and is expected
to grow at a moderate rate, with a CAGR of
approximately 4 from 2011 to 2015. In addition,
intravenous anesthetic drugs accounted for the
largest share 65 of the U.S. general
anesthetics drugs market in 2011. - 4. Ketamine is an anesthetic drug mainly used
for initiation and maintenance of general
anesthesia in humans. It belongs to NMDA receptor
antagonist class, which includes molecules that
prevent the action of the N-methyl D-aspartate
(NMDA) receptor. Factors such as increase in
aging population, rising cardiovascular, and
respiratory system related diseases and rising
number of emergency surgeries will help in
maintaining stable growth in the ketamine market
revenue in the next five years along with the
overall growth of the U.S. general intravenous
anesthesia market.
5Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
MarketsandMarkets Blog http//twitter.com/marke
tsmarkets
http//www.linkedin.com/company/marketsandmarkets
6About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.